Bio-Rad Laboratories (BIO) Consolidated Net Income (2016 - 2026)
Bio-Rad Laboratories has reported Consolidated Net Income over the past 18 years, most recently at -$527.1 million for Q1 2026.
- Quarterly Consolidated Net Income fell 923.59% to -$527.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $168.8 million through Mar 2026, up 107.8% year-over-year, with the annual reading at $759.9 million for FY2025, 141.2% up from the prior year.
- Consolidated Net Income was -$527.1 million for Q1 2026 at Bio-Rad Laboratories, down from $720.0 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at $827.8 million in Q4 2022 and troughed at -$3.4 billion in Q1 2022.
- The 5-year median for Consolidated Net Income is $64.0 million (2025), against an average of -$345.7 million.
- Year-over-year, Consolidated Net Income surged 514.75% in 2024 and then crashed 923.59% in 2026.
- A 5-year view of Consolidated Net Income shows it stood at $827.8 million in 2022, then plummeted by 57.75% to $349.7 million in 2023, then plummeted by 304.67% to -$715.8 million in 2024, then skyrocketed by 200.59% to $720.0 million in 2025, then tumbled by 173.21% to -$527.1 million in 2026.
- Per Business Quant, the three most recent readings for BIO's Consolidated Net Income are -$527.1 million (Q1 2026), $720.0 million (Q4 2025), and -$341.9 million (Q3 2025).